Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Appropriations

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹30,287 Cr₹27,083 Cr₹24,446 Cr₹22,785 Cr₹20,377 Cr

What is the latest Appropriations of AUROBINDO PHARMA ?

The latest Appropriations ratio of AUROBINDO PHARMA is ₹30,287 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹30,287 Cr
Mar2024₹27,083 Cr
Mar2023₹24,446 Cr
Mar2022₹22,785 Cr
Mar2021₹20,377 Cr

How is Appropriations of AUROBINDO PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹30,287 Cr
11.83
Mar2024 ₹27,083 Cr
10.79
Mar2023 ₹24,446 Cr
7.29
Mar2022 ₹22,785 Cr
11.82
Mar2021 ₹20,377 Cr -

Compare Appropriations of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,358.3 Cr 0.2% 1.7% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.2%

1.7%

3.4%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses